Handelsbanken Fonder’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $70.8M | Buy |
|
|||||
|
2025
Q2 | $50.7M | Buy |
|
|||||
|
2025
Q1 | $31.5M | Buy |
|
|||||
|
2024
Q4 | $12.8M | Sell |
|
|||||
|
2024
Q3 | $20.1M | Buy |
|
|||||
|
2024
Q2 | $17.8M | Sell |
|
|||||
|
2024
Q1 | $11.2M | Buy |
|
|||||
|
2023
Q4 | $14.3M | Sell |
|
|||||
|
2023
Q3 | $30.1M | Buy |
|
|||||
|
2023
Q2 | $32.2M | Sell |
|
|||||
|
2023
Q1 | $34.3M | Sell |
|
|||||
|
2022
Q4 | $45.7M | Buy |
|
|||||
|
2022
Q3 | $25.5M | Sell |
|
|||||
|
2022
Q2 | $25.1M | Buy |
|
|||||
|
2022
Q1 | $28M | Sell |
|
|||||
|
2021
Q4 | $31.8M | Buy |
|
|||||
|
2021
Q3 | $3.79M | Buy |
|
|||||
|
2021
Q2 | $3.24M | Sell |
|
|||||
|
2021
Q1 | $2.87M | Sell |
|
|||||
|
2020
Q4 | $2.82M | Buy |
|
|||||
|
2020
Q3 | $2.8M | Hold |
|
|||||
|
2020
Q2 | $2.84M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $598K | Buy |
|